Literature DB >> 4232743

Trial of an anti-inflammatory agent (indomethacin) in low back pain with and without radicular involvement.

J H Jacobs, M F Grayson.   

Abstract

A short-term double-blind sequential trial of indomethacin against placebo in the treatment of low back pain, with and without nerve root pain such as sciatica, showed that indomethacin was significantly more effective than placebo in the group with nerve root pain. On the other hand, no difference was found between the treatments in the patients with uncomplicated low back pain. This difference may result from an effect of indomethacin on the inflammatory process around the nerve root which has been shown to be present when this is compressed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4232743      PMCID: PMC1986152          DOI: 10.1136/bmj.3.5611.158

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  INDOMETHACIN IN RHEUMATIC DISEASES. A CONTROLLED CLINICAL TRIAL.

Authors:  J WANKA; L I JONES; P H WOOD; A S DIXON
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  ANALGESIC STUDIES OF INDOMETHACIN AS ANALYZED BY COMPUTER TECHNIQUES.

Authors:  A SUNSHINE; E LASKA; M MEISNER; S MORGAN
Journal:  Clin Pharmacol Ther       Date:  1964 Nov-Dec       Impact factor: 6.875

3.  [Results of microscopic examination of the spinal nerve roots in lumbar and lumbosacral (dorsolateral) disk prolapse].

Authors:  F J IRSIGLER
Journal:  Acta Neurochir (Wien)       Date:  1951       Impact factor: 2.216

4.  Indomethacin and phenylbutazone: a comparison.

Authors:  F D Hart; P L Boardman
Journal:  Br Med J       Date:  1965-11-27

5.  Further experience with indomethacin in the treatment of rheumatic disorders.

Authors:  M Thompson; J S Percy
Journal:  Br Med J       Date:  1966-01-08

6.  An extended study of indomethacin. II. Clinical therapy.

Authors:  N O Rothermich
Journal:  JAMA       Date:  1966-03-28       Impact factor: 56.272

7.  ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  J Pharmacol Exp Ther       Date:  1963-09       Impact factor: 4.030

  7 in total
  6 in total

Review 1.  Outcome of non-invasive treatment modalities on back pain: an evidence-based review.

Authors:  Maurits W van Tulder; Bart Koes; Antti Malmivaara
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

2.  A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease.

Authors:  David M Marks; Chi-Un Pae; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-08-14

Review 3.  Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials.

Authors:  B W Koes; R J Scholten; J M Mens; L M Bouter
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

Review 4.  Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.

Authors:  Andrea L Nicol; Robert W Hurley; Honorio T Benzon
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

Review 5.  Non-steroidal anti-inflammatory drugs for chronic low back pain.

Authors:  Wendy T M Enthoven; Pepijn D D M Roelofs; Richard A Deyo; Maurits W van Tulder; Bart W Koes
Journal:  Cochrane Database Syst Rev       Date:  2016-02-10

6.  Non-steroidal anti-inflammatory drugs for acute low back pain.

Authors:  Wendelien H van der Gaag; Pepijn Ddm Roelofs; Wendy Tm Enthoven; Maurits W van Tulder; Bart W Koes
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.